Drug Type Monoclonal antibody |
Synonyms MV 088, MV-088, MV088 |
Target |
Action inhibitors |
Mechanism RANKL inhibitors(Tumor necrosis factor ligand superfamily member 11 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoporosis, Postmenopausal | Phase 1 | China | 27 Nov 2020 | |
Neoplasms | IND Application | China | 29 Oct 2019 |